The Application of MSCs-Derived Extracellular Vesicles in Bone Disorders: Novel Cell-Free Therapeutic Strategy

Shuyu Liu,Xia Xu,Shujing Liang,Zhihao Chen,Yan Zhang,Airong Qian,Lifang Hu

DOI: https://doi.org/10.3389/fcell.2020.00619

IF: 5.5

2020-07-22

Frontiers in Cell and Developmental Biology

Abstract:Bone is crucial for supporting the body, protecting other organs, providing minerals, and secreting hormone to regulate other organ's function. Bone disorders result in pain and disability, severely affecting human health, reducing the quality of life and increasing costs to society. With the rapid increase in the aging population worldwide, bone disorders have become one major disease. As a result, efficacious therapies of bone disorders have become the focus of attention worldwide. Mesenchymal stem cells (MSCs) have been widely explored as a new therapeutic method for numerous diseases. Recent evidence suggests that the therapeutic effects of MSCs are mainly mediated by their extracellular vesicles (EV). MSCs-derived extracellular vesicles (MSCs-EV) is indicated as a novel cell-free alternative to cell therapy with MSCs in regenerative medicine. Here, we review the current knowledge of EV and highlight the application studies of MSCs-EV in bone disorders by focusing on osteoarthritis (OA), rheumatoid arthritis (RA), osteoporosis (OP), and bone fracture. Moreover, we discuss the key issues and perspectives of MSCs-EV as a clinical therapeutic strategy for bone diseases.

cell biology,developmental biology

What problem does this paper attempt to address?

The paper primarily explores the application of mesenchymal stem cell (MSC)-derived extracellular vesicles (MSC-EV) in the treatment of bone diseases, proposing a novel acellular therapy approach. Specifically, the paper focuses on the following bone diseases:

1. **Osteoarthritis (OA)**
2. **Rheumatoid Arthritis (RA)**
3. **Osteoporosis (OP)**
4. **Bone Fracture**

The paper points out that with the rapid increase in the global aging population, bone diseases have become a major concern, and effective treatment methods are highly sought after. Mesenchymal stem cells, due to their self-renewal capability and multipotent differentiation potential, have broad application prospects in regenerative medicine. However, there are some challenges associated with the direct use of MSCs for treatment, such as genetic instability, loss of function, pathogenicity, and low cell survival rates.

Recent studies have shown that the primary therapeutic effects of MSCs are achieved through their paracrine mechanisms, with extracellular vesicles (EV) being the key mediators. Compared to the direct use of MSCs, MSC-EV therapy offers higher safety, ease of storage, transportation, and administration. Therefore, the paper focuses on reviewing the application research of MSC-EV in the aforementioned bone diseases and discusses the key issues and prospects of their use as clinical treatment strategies.